FindTrial
Sign In

A randomised controlled trial of oral prednisolone for viral-wheeze in pre-school children with stratification for serum level of Eosinophil Protein X (EPX)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN78625210
Enrollment
Unknown
Registered
2004-01-23
Start date
1999-03-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory tract diseases: Asthma Respiratory Asthma

Interventions

Children passing the inclusion criteria will be divided into two groups a. Those with presenting serum EPX levels of greater than or equal to 25 ug/l b. Those with EPX levels <25 ug/l. At the next epi

Sponsors

Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children aged between 18 and 48 months of age presenting with viral-wheeze.

Exclusion criteria

Exclusion criteria: No exclusion criteria

Design outcomes

Primary

MeasureTime frame
Outcome will be assessed by parental scoring of respiratory symptoms using a diary card.—

Secondary

MeasureTime frame
No secondary outcome measures—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026